clofibric acid has been researched along with Hyperlipoproteinemia Type I in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Hyperlipoproteinemia Type I: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niacin was started after recurrence." | 1.36 | Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report. ( Lupattelli, G; Mannarino, E; Roscini, AR; Siepi, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lupattelli, G | 1 |
| Roscini, AR | 1 |
| Siepi, D | 1 |
| Mannarino, E | 1 |
1 other study available for clofibric acid and Hyperlipoproteinemia Type I
| Article | Year |
|---|---|
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-Co | 2010 |